The mobile everyday cognition scale (mECog): development and pilot testing.

IF 3 3区 心理学 Q2 CLINICAL NEUROLOGY Clinical Neuropsychologist Pub Date : 2024-07-26 DOI:10.1080/13854046.2024.2383333
Sawyer Harmon, Courtney G Kocum, Rylea M Ranum, Greta Hermann, Sarah Tomaszewski Farias, Andrew M Kiselica
{"title":"The mobile everyday cognition scale (mECog): development and pilot testing.","authors":"Sawyer Harmon, Courtney G Kocum, Rylea M Ranum, Greta Hermann, Sarah Tomaszewski Farias, Andrew M Kiselica","doi":"10.1080/13854046.2024.2383333","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Subjective cognitive decline (SCD) is an important part of the aging process and may be a sign of neurodegenerative disease. Current measures of SCD are subject to the limits of retrospective recall of symptoms over a long span of time, which might be addressed by using ecological momentary assessment (EMA) methods. However, there are no currently available measures of SCD validated for use in EMA. Thus, our goal was to develop and pilot test the mobile Everyday Cognition Scale (mECog). <b>Method:</b> 31 community-dwelling older adults completed in lab measures of cognition and mental health symptoms, followed by daily mECog ratings on a smart phone for 28 days. <b>Results:</b> Most participants completed at least 75% of mECog assessments (<i>n</i> = 27, 87%), and the average number of assessments completed was 22. Further, respondents rated the mobile assessment platform and measures as easy to use and non-interfering with daily life. Test-retest reliability of mECog scores was very strong (<i>R<sub>KRN</sub></i> = .99), and within-person reliability was moderate (<i>R<sub>CN</sub></i> = .41). mECog scores demonstrated strong positive associations with scores from the original ECog (<i>ρ</i> = .62-69, <i>p</i> < .001) and short form ECog (<i>ρ</i> = .63-.69, <i>p</i> < .001) and non-significant associations with demographics (<i>ρ</i> = -0.25-.04, <i>p</i> = .21-.94) and mental health symptoms (<i>ρ</i> = -0.06-.34, <i>p</i> = .08-.99). mECog scores also exhibited small-to-moderate negative correlations with objective cognitive test scores, though these relationships did not reach statistical significance (<i>ρ</i> = -0.32 to -0.22, <i>p</i> = .10-.27). <b>Conclusions:</b> Results suggest that mobile assessment of SCD <i>via</i> the mECog is feasible and acceptable. Further, mECog scores demonstrated good psychometric properties, including evidence of strong reliability, convergent validity, and divergent validity.</p>","PeriodicalId":55250,"journal":{"name":"Clinical Neuropsychologist","volume":" ","pages":"1-20"},"PeriodicalIF":3.0000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychologist","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/13854046.2024.2383333","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Subjective cognitive decline (SCD) is an important part of the aging process and may be a sign of neurodegenerative disease. Current measures of SCD are subject to the limits of retrospective recall of symptoms over a long span of time, which might be addressed by using ecological momentary assessment (EMA) methods. However, there are no currently available measures of SCD validated for use in EMA. Thus, our goal was to develop and pilot test the mobile Everyday Cognition Scale (mECog). Method: 31 community-dwelling older adults completed in lab measures of cognition and mental health symptoms, followed by daily mECog ratings on a smart phone for 28 days. Results: Most participants completed at least 75% of mECog assessments (n = 27, 87%), and the average number of assessments completed was 22. Further, respondents rated the mobile assessment platform and measures as easy to use and non-interfering with daily life. Test-retest reliability of mECog scores was very strong (RKRN = .99), and within-person reliability was moderate (RCN = .41). mECog scores demonstrated strong positive associations with scores from the original ECog (ρ = .62-69, p < .001) and short form ECog (ρ = .63-.69, p < .001) and non-significant associations with demographics (ρ = -0.25-.04, p = .21-.94) and mental health symptoms (ρ = -0.06-.34, p = .08-.99). mECog scores also exhibited small-to-moderate negative correlations with objective cognitive test scores, though these relationships did not reach statistical significance (ρ = -0.32 to -0.22, p = .10-.27). Conclusions: Results suggest that mobile assessment of SCD via the mECog is feasible and acceptable. Further, mECog scores demonstrated good psychometric properties, including evidence of strong reliability, convergent validity, and divergent validity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
移动日常认知量表(mECog):开发与试点测试。
目的:主观认知能力下降(SCD)是衰老过程的重要组成部分,也可能是神经退行性疾病的征兆。目前的 SCD 测量方法受到长期症状回顾的限制,而生态瞬间评估(EMA)方法可以解决这一问题。然而,目前还没有经过验证可用于 EMA 的 SCD 测量方法。因此,我们的目标是开发并试点测试移动日常认知量表(mECog)。方法:31 位居住在社区的老年人在实验室完成了认知和心理健康症状的测量,随后在智能手机上进行了为期 28 天的每日 mECog 评分。结果大多数参与者完成了至少 75% 的 mECog 评估(n = 27,87%),平均完成 22 次评估。此外,受访者认为移动评估平台和测量方法易于使用,不会干扰日常生活。mECog 分数与原始 ECog 分数有很强的正相关性(ρ = .62-69,p ρ = .63-.69,p ρ = -0.25-.04,p = .mECog 分数还与客观认知测试分数呈小到中等程度的负相关,但这些关系未达到统计学意义(ρ = -0.32 至 -0.22,p = .10-.27)。结论:结果表明,通过 mECog 对 SCD 进行移动评估是可行且可接受的。此外,mECog 分数显示出良好的心理测量特性,包括较强的可靠性、收敛有效性和发散有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Neuropsychologist
Clinical Neuropsychologist 医学-临床神经学
CiteScore
8.40
自引率
12.80%
发文量
61
审稿时长
6-12 weeks
期刊介绍: The Clinical Neuropsychologist (TCN) serves as the premier forum for (1) state-of-the-art clinically-relevant scientific research, (2) in-depth professional discussions of matters germane to evidence-based practice, and (3) clinical case studies in neuropsychology. Of particular interest are papers that can make definitive statements about a given topic (thereby having implications for the standards of clinical practice) and those with the potential to expand today’s clinical frontiers. Research on all age groups, and on both clinical and normal populations, is considered.
期刊最新文献
Development of a Symptom Validity Index for the Beck Anxiety Inventory. Interpreting the direct- and derived-Trail Making Test scores in Argentinian children: regression-based norms, convergent validity, test-retest reliability, and practice effects. Enhanced detection of suboptimal effort in psychoeducational assessments for dyslexia. Neuropsychological normative standards for late career physicians. Naturalistic assessment of everyday multitasking in Parkinson's disease with and without mild cognitive impairment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1